For how we live.
Researchers searched in four languages across three engines. One in ten clinics said it would prescribe testosterone to men with normal levels; one in five claimed it cuts cardiovascular risk.
The randomised evidence in older men found a moderate effect on sexual function and none on vitality or walking. A 5,246-man safety trial cleared it on heart attacks and found more fractures.
ALEG's position holds that testosterone in postmenopausal women should be limited to hypoactive sexual desire disorder, and that pellets and compounded formulations are not recommended.